Lista de obras - Núria Pérez-Álvarez - Dominio Público Uruguay

A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.

artículo científico publicado en 2013

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

scientific article published on 17 September 2020

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus

artículo científico publicado en 2008

Adherence and health beliefs in a psychoeducative intervention in naïve HIV-1-infected men: the PROADH study.

artículo científico publicado en 2012

Adherence, coping strategies and depression in highly antiretroviral-experienced patients

scholarly article by CR Fumaz et al published 2008 in Journal of the International AIDS Society

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

artículo científico publicado en 2007

Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.

artículo científico publicado en 2007

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

artículo científico publicado en 2010

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

artículo científico publicado en 2014

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men.

artículo científico publicado en 2016

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years

artículo científico publicado en 2015

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

artículo científico publicado en 2013

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

artículo científico publicado en 2008

Dispositional optimism, perceived health competence and adherence in highly antiretroviral-experienced patients

article

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

artículo científico publicado en 2013

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

artículo científico publicado en 2011

Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection

artículo científico publicado en 2013

Emotional impact of premature aging symptoms in long-term treated HIV-infected subjects.

artículo científico publicado en 2012

Epistasis among deleterious mutations in the HIV-1 protease

artículo científico publicado en 2009

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy

artículo científico publicado en 2009

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

artículo científico publicado en 2009

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

artículo científico publicado en 2010

High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.

artículo científico publicado en 2014

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

artículo científico publicado en 2012

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

artículo científico publicado en 2018

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259-264. Methodological accuracy in cross-trial comparisons

scientific article published on 01 November 2007

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers

artículo científico publicado en 2020

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

artículo científico publicado en 2010

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

artículo científico publicado en 2016

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

artículo científico publicado en 2014

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

artículo científico publicado en 2009

In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies

artículo científico publicado en 2016

Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress

artículo científico publicado en 2009

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.

artículo científico publicado en 2007

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

artículo científico publicado en 2010

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

article

Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine

artículo científico publicado en 2009

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

artículo científico publicado en 2005

Long-term satisfaction and benefits on quality of life in HIV-infected people after reparatory treatment with Aquamid® for facial Lipoatrophy

article

Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders

artículo científico publicado en 2009

Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content

artículo científico publicado en 2010

Mitochondrial effects of 3 years of CD4-guided HIV treatment interruption

article

Monotherapy with boosted PIs as an ART simplification strategy in clinical practice

artículo científico publicado en 2014

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

article

NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV

artículo científico publicado en 2019

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

article

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

artículo científico publicado en 2008

Peak bone mass in young HIV-infected patients compared with healthy controls

artículo científico publicado en 2014

Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity

artículo científico publicado en 2017

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

artículo científico publicado en 2020

Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates

artículo científico publicado en 2010

Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients

artículo científico publicado en 2014

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.

artículo científico publicado en 2017

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

artículo científico publicado en 2016

Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment

artículo científico publicado en 2012

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

scientific article published on 01 January 2014

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

artículo científico publicado en 2012

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

artículo científico publicado en 2014

Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.

artículo científico publicado en 2006

Resilience, ageing, and quality of life in long-term diagnosed HIV-infected patients

artículo científico publicado en 2015

Reversal of HIV-1-associated osteoporosis with once-weekly alendronate

artículo científico publicado en 2005

Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients

artículo científico publicado en 2010

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

artículo científico publicado en 2016

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).

artículo científico publicado en 2009

Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice

scientific article published on 08 May 2019

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

artículo científico publicado en 2015

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

artículo científico publicado en 2013

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

artículo científico publicado en 2008

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

artículo científico publicado en 2006

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

artículo científico publicado en 2012

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

artículo científico publicado en 2017

Transient therapy with quadruple NRTI provides immune stability in patients with multidrug resistant HIV-1 and no options for suppressive regimens

article

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.

artículo científico publicado en 2008

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort

artículo científico publicado en 2010

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

artículo científico publicado en 2017

Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial

artículo científico publicado en 2016

Lista de obras de Núria Pérez-Álvarez

A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus

Adherence and health beliefs in a psychoeducative intervention in naïve HIV-1-infected men: the PROADH study.

Adherence, coping strategies and depression in highly antiretroviral-experienced patients

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men.

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

Dispositional optimism, perceived health competence and adherence in highly antiretroviral-experienced patients

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection

Emotional impact of premature aging symptoms in long-term treated HIV-infected subjects.

Epistasis among deleterious mutations in the HIV-1 protease

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259-264. Methodological accuracy in cross-trial comparisons

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies

Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress

Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

Long-term satisfaction and benefits on quality of life in HIV-infected people after reparatory treatment with Aquamid® for facial Lipoatrophy

Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders

Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content

Mitochondrial effects of 3 years of CD4-guided HIV treatment interruption

Monotherapy with boosted PIs as an ART simplification strategy in clinical practice

Mutations in the protease gene associated with virological failure to lopinavir-containing regimens in clinical samples

NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

Peak bone mass in young HIV-infected patients compared with healthy controls

Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates

Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.

Resilience, ageing, and quality of life in long-term diagnosed HIV-infected patients

Reversal of HIV-1-associated osteoporosis with once-weekly alendronate

Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).

Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

Transient therapy with quadruple NRTI provides immune stability in patients with multidrug resistant HIV-1 and no options for suppressive regimens

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial